JP7117779B2 - 食品ペプチド - Google Patents

食品ペプチド Download PDF

Info

Publication number
JP7117779B2
JP7117779B2 JP2018551497A JP2018551497A JP7117779B2 JP 7117779 B2 JP7117779 B2 JP 7117779B2 JP 2018551497 A JP2018551497 A JP 2018551497A JP 2018551497 A JP2018551497 A JP 2018551497A JP 7117779 B2 JP7117779 B2 JP 7117779B2
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acid
sequence
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018551497A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019505572A5 (enExample
JP2019505572A (ja
Inventor
ヤン・ステイステズ
ジエホイ・ジョウ
ランディ・イェッセン
ヨハン・パルムフェルト
エリク・トアンゴー・ハンセン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diet4life Aps
Original Assignee
Diet4life Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diet4life Aps filed Critical Diet4life Aps
Publication of JP2019505572A publication Critical patent/JP2019505572A/ja
Publication of JP2019505572A5 publication Critical patent/JP2019505572A5/ja
Application granted granted Critical
Publication of JP7117779B2 publication Critical patent/JP7117779B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2018551497A 2015-12-16 2016-12-16 食品ペプチド Active JP7117779B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15200440.4 2015-12-16
EP15200440 2015-12-16
PCT/EP2016/081572 WO2017103200A1 (en) 2015-12-16 2016-12-16 Dietary peptides

Publications (3)

Publication Number Publication Date
JP2019505572A JP2019505572A (ja) 2019-02-28
JP2019505572A5 JP2019505572A5 (enExample) 2020-01-23
JP7117779B2 true JP7117779B2 (ja) 2022-08-15

Family

ID=55068774

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018551497A Active JP7117779B2 (ja) 2015-12-16 2016-12-16 食品ペプチド

Country Status (11)

Country Link
US (2) US11259554B2 (enExample)
EP (1) EP3390425B1 (enExample)
JP (1) JP7117779B2 (enExample)
KR (1) KR102863433B1 (enExample)
CN (1) CN108473535A (enExample)
AU (1) AU2016372510B2 (enExample)
BR (1) BR112018012353A2 (enExample)
MX (1) MX2018007212A (enExample)
RU (1) RU2018125630A (enExample)
WO (1) WO2017103200A1 (enExample)
ZA (1) ZA201804124B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3938037A1 (en) * 2019-03-15 2022-01-19 Diet4Life ApS Combination of dietary peptides
US20230042729A1 (en) * 2019-03-15 2023-02-09 Diet4Life Aps Peptide constructs and compositions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008001045A1 (en) 2006-06-26 2008-01-03 Ares Trading S.A. Members of the glycoside hydrolase family 31 family of proteins
WO2008074329A2 (en) 2006-12-21 2008-06-26 Neuronicon Aps Modulation of activity of proneurotrophins
US20090082265A1 (en) 2002-01-04 2009-03-26 Myriad Genetics, Incorporated Compositions and methods for treating diseases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0848634A (ja) 1994-08-05 1996-02-20 Akio Okamoto 角膜治療剤
US7214786B2 (en) 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
US7923253B2 (en) * 2007-11-05 2011-04-12 Battelle Memorial Institute Method for identifying type I diabetes mellitus in humans
KR101003364B1 (ko) * 2008-04-24 2011-01-07 대한민국 한우 등심 판별용 바이오 마커 단백질
CN102348723A (zh) * 2008-12-05 2012-02-08 安吉奥开米公司 肽治疗剂轭合物及其应用
WO2011005893A2 (en) * 2009-07-07 2011-01-13 Abbott Laboratories Biomarkers and methods for detecting alzheimer's disease
GB201001333D0 (en) 2010-01-27 2010-03-17 Imp Innovations Ltd Novel compounds and their effects on feeding behaviour
WO2011119484A1 (en) 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
EP3048904A2 (en) 2013-09-25 2016-08-03 Pronutria Biosciences, Inc. Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
WO2017100700A2 (en) * 2015-12-11 2017-06-15 Fred Hutchinson Cancer Research Center Peptides for renal therapy
EP3938037A1 (en) * 2019-03-15 2022-01-19 Diet4Life ApS Combination of dietary peptides
US20230042729A1 (en) * 2019-03-15 2023-02-09 Diet4Life Aps Peptide constructs and compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090082265A1 (en) 2002-01-04 2009-03-26 Myriad Genetics, Incorporated Compositions and methods for treating diseases
WO2008001045A1 (en) 2006-06-26 2008-01-03 Ares Trading S.A. Members of the glycoside hydrolase family 31 family of proteins
WO2008074329A2 (en) 2006-12-21 2008-06-26 Neuronicon Aps Modulation of activity of proneurotrophins

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Bernadette Cusack et al.，The Journal of Biological Chemistry，1995年，Vol.270, No.31，p.18359-18366
Gary A. Cain et al.，Bioorganic & Medicinal Chemsitry Letters，1993年，Vol.3, No.8，p.1767-1772
Thomas E.Christos et al.，Bioorganic & Medicinal Chemistry Letters，1993年，Vol.3, No.6，p.1035-1040

Also Published As

Publication number Publication date
US12295397B2 (en) 2025-05-13
KR20180087433A (ko) 2018-08-01
ZA201804124B (en) 2024-11-27
EP3390425C0 (en) 2024-08-07
AU2016372510A1 (en) 2018-06-28
RU2018125630A3 (enExample) 2020-02-26
RU2018125630A (ru) 2020-01-20
BR112018012353A2 (en) 2018-12-04
US20180368459A1 (en) 2018-12-27
MX2018007212A (es) 2018-11-09
US20220248736A1 (en) 2022-08-11
CA3007436A1 (en) 2017-06-22
EP3390425A1 (en) 2018-10-24
US11259554B2 (en) 2022-03-01
AU2016372510B2 (en) 2021-07-08
CN108473535A (zh) 2018-08-31
EP3390425B1 (en) 2024-08-07
WO2017103200A1 (en) 2017-06-22
NZ743368A (en) 2025-08-29
KR102863433B1 (ko) 2025-09-23
JP2019505572A (ja) 2019-02-28

Similar Documents

Publication Publication Date Title
JP5068174B2 (ja) Ｄｐｐ−ｉｖを阻害するペプチド中に濃縮されたタンパク質の加水分解物及びその使用
Sharma et al. Bioactive peptides: a review
McCann et al. Isolation and characterisation of a novel antibacterial peptide from bovine αS1-casein
Wang et al. A new frontier in soy bioactive peptides that may prevent age‐related chronic diseases
KR101095698B1 (ko) 콜라겐 펩티드 조성물 및 이것을 함유하는 음식품
Tidona et al. Bioactive peptides in dairy products
US20090270309A1 (en) Use of lactoferrin fragments and hydrolysates
Reyes‐Díaz et al. Immunomodulation by hydrolysates and peptides derived from milk proteins
Moughan et al. Food-derived bioactive peptides–a new paradigm
KR20160056941A (ko) 당뇨병 및 비만의 예방 및 치료를 위한 조성물 및 제형, 그리고 글루코스 및 열량 제어에서 이들의 생성방법 및 용도
RU2766585C2 (ru) Способы индуцирования и пролонгирования насыщения, уменьшения объёма и поглощения пищи, контроля веса и стимулирования снижения веса
US20120040908A1 (en) Fracture repair promoter
WO2010125192A1 (en) Use of a casein-derived peptide and compositions thereof as antihypertensive
US12295397B2 (en) Dietary peptides
US20230042729A1 (en) Peptide constructs and compositions
Wang et al. Purification and identification of an ACE-inhibitory peptide from walnut protein hydrolysate
Hajirostamloo Bioactive component in milk and dairy product
CN106661087A (zh) 用于改善哺乳动物血糖控制的肽及其组合物
US20220315632A1 (en) Combination of dietary peptides
CA3007436C (en) Dietary peptides
Sufian et al. Soybean β-conglycinin bromelain hydrolysate stimulates cholecystokinin secretion by enteroendocrine STC-1 cells to suppress the appetite of rats under meal-feeding conditions
KR20150110529A (ko) 포만 호르몬 방출 활성을 갖는 신규 폴리펩티드
TW202016128A (zh) 胜肽、組成物以及治療、預防或改善情緒障礙之方法
XU Department of Zoology The University of Hong Kong, Hong Kong
CN121358342A (zh) 提升的乳质

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201222

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210621

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210817

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220519

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220628

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220726

R150 Certificate of patent or registration of utility model

Ref document number: 7117779

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250